Hims & Hers Health 
HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss.
Growth Drivers:
Weight Loss Service Momentum ⚡
Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlocked a major new revenue stream.
Strong adoption is fueling accelerated growth.
Subscriber & Revenue Growth 📊
Q2 2025 subscribers surged 31–38% YoY to 2.4M.
Monthly revenue per subscriber jumped 30% to $74, reflecting deeper engagement.
Operational Leverage 🤖
AI-driven care and pharmacy automation are enhancing scalability and margins.
Partnership expansions are broadening reach and improving efficiency.
Investment Outlook:
Bullish Case: We remain bullish above $54.00–$55.00, supported by high-margin recurring revenue and strong subscriber momentum.
Upside Potential: Target: $110.00–$115.00, driven by continued adoption of GLP-1 programs, tech-enabled scalability, and strategic partnerships.
📢 HIMS—Scaling Digital Healthcare with AI, Innovation, and Strong Subscriber Economics. #HIMS #Telehealth #GLP1 #DigitalHealth #GrowthStocks
HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss.Growth Drivers:
Weight Loss Service Momentum ⚡
Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlocked a major new revenue stream.
Strong adoption is fueling accelerated growth.
Subscriber & Revenue Growth 📊
Q2 2025 subscribers surged 31–38% YoY to 2.4M.
Monthly revenue per subscriber jumped 30% to $74, reflecting deeper engagement.
Operational Leverage 🤖
AI-driven care and pharmacy automation are enhancing scalability and margins.
Partnership expansions are broadening reach and improving efficiency.
Investment Outlook:
Bullish Case: We remain bullish above $54.00–$55.00, supported by high-margin recurring revenue and strong subscriber momentum.
Upside Potential: Target: $110.00–$115.00, driven by continued adoption of GLP-1 programs, tech-enabled scalability, and strategic partnerships.
📢 HIMS—Scaling Digital Healthcare with AI, Innovation, and Strong Subscriber Economics. #HIMS #Telehealth #GLP1 #DigitalHealth #GrowthStocks
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.